Latest Breaking News On - Julie schneiderman - Page 9 : comparemela.com

Theratechnologies Announces All U S Oncology Clinical Sites Now Enrolling for Phase 1 Trial of Sudocetaxel Zendusortide

MONTREAL, Aug. 30, 2023 (GLOBE NEWSWIRE) Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmac.

Julie schneidermanPhilippe dubucSudocetaxel zendusortideCommunications corporate affairsTheratechnologies incCompany phaseForward looking statementsLooking statementsAnnual information formVice presidentChief financial officer

Theratechnologies Announces All U S Oncology Clinical Sites Now Enrolling for Phase 1 Trial of

MONTREAL, Aug. 30, 2023 (GLOBE NEWSWIRE) Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today

Philippe dubucJulie schneidermanSudocetaxel zendusortideCommunications corporate affairsTheratechnologies incCompany phaseForward looking statementsLooking statementsAnnual information formVice presidentChief financial

Theratechnologies Announces the Resignation of One of Its Directors, Mr Gary Littlejohn

MONTREAL, July 21, 2023 Theratechnologies Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Mr. Gary Littlejohn.

Julie schneidermanGary littlejohnPhilippe dubucCompensation committeeCommunications corporate affairsBoard of directors the companyTheratechnologies incAudit committeeDawn svoronosForward looking statementsAnnual information formVice presidentChief financial

Theratechnologies Announces the Resignation of One of Its Directors, Mr Gary Littlejohn

Theratechnologies Announces the Resignation of One of Its Directors, Mr Gary Littlejohn
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Julie schneidermanGary littlejohnPhilippe dubucAudit committeeCompensation committeeTheratechnologies incCommunications corporate affairsBoard of directors the companyDawn svoronosForward looking statementsAnnual information formVice presidentChief financial

Theratechnologies Reports Second Quarter 2023 Financial Results and Business Updates

Theratechnologies Reports Second Quarter 2023 Financial Results and Business Updates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJulie schneidermanJohn leasurePhilippe dubucSudocetaxel zendusortideChristian marsolaisCommunications corporate affairsInternational financial reporting standardsDrug administrationCompany loan facilityAmerican society of clinical oncologyEpidemiology research analysisTheratechnologies incSudocetaxel zendusortide development pathwaySecond quarterFirst half fiscal